Hampel, H, Shaw, LM, Aisen, P, Chen, C, Lleo, A, Iwatsubo, T, Iwata, A, Yamada, M, Ikeuchi, T, Jia, JP, Wang, HL, Teunissen, CE, Peskind, E, Blennow, K, Cummings, J, Vergallo, A. State-of-the-art of lumbar puncture and its place in the journey of patients with Alzheimer's disease. ALZHEIMERS & DEMENTIA. 2022; 18(1)DOI:10.1002/alz.12372. PMID:34043269. IF:14.000(Q1/1D).

Illan-Gala, I, Casaletto, KB, Borrego-Ecija, S, Arenaza-Urquijo, EM, Wolf, A, Cobigo, Y, Goh, SYM, Staffaroni, AM, Alcolea, D, Fortea, J, Blesa, R, Clarimon, J, Iulita, MF, Brugulat-Serrat, A, Llado, A, Grinberg, LT, Possin, K, Rankin, KP, Kramer, JH, Rabinovici, GD, Boxer, A, Seeley, WW, Sturm, VE, Gorno-Tempini, ML, Miller, BL, Sanchez-Valle, R, Perry, DC, Lleo, A, Rosen, HJ. Sex differences in the behavioral variant of frontotemporal dementia: A new window to executive and behavioral reserve. ALZHEIMERS & DEMENTIA. 2021; 17(8)DOI:10.1002/alz.12299. PMID:33590953. IF:16.655(Q1/1D).

del Campo, M, Zetterberg, H, Gandy, S, Onyike, CU, Oliveira, F, Udeh-Momoh, C, Lleo, A, Teunissen, CE, Pijnenburg, Y. New developments of biofluid-based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia. ALZHEIMERS & DEMENTIA. 2022; 18(11)DOI:10.1002/alz.12643. PMID:35235699. IF:14.000(Q1/1D).

Badhwar, A, Hirschberg, Y, Valle-Tamayo, N, Iulita, MF, Udeh-Momoh, CT, Matton, A, Tarawneh, RM, Rissman, RA, Ledreux, A, Winston, CN, Haqqani, AS. Assessment of brain-derived extracellular vesicle enrichment for blood biomarker analysis in age-related neurodegenerative diseases: An international overview. ALZHEIMERS & DEMENTIA. 2024; 20(7)DOI:10.1002/alz.13823. PMID:38864416. IF:11.100(Q1/1D).

Videla L., Benejam B., Carmona-Iragui M., Barroeta I., Fernández S., Arranz J., Azzahchi S.E., Altuna M., Padilla C., Valldeneu S., Pegueroles J., Montal V., Aranha M.R., Vaqué-Alcázar L., Iulita M.F., Alcolea D., Bejanin A., Videla S., Blesa R., Lleó A., Fortea J.. Cross-sectional versus longitudinal cognitive assessments for the diagnosis of symptomatic Alzheimer's disease in adults with Down syndrome. ALZHEIMERS & DEMENTIA. 2023; 19(9)DOI:10.1002/alz.13073. PMID:37038748. IF:13.100(Q1/1D).

Aranha, MR, Iulita M.F., Montal V., Pegueroles J., Bejanin A., Vaqué-Alcázar L., Grothe M.J., Carmona-Iragui M., Videla L., Benejam B., Arranz J., Padilla C., Valldeneu S., Barroeta I., Altuna M., Fernández S., Ribas L., Valle-Tamayo N., Alcolea D., González-Ortiz S., Bargalló N., Zetterberg H., Blennow K., Blesa R., Wisniewski T., Busciglio J., Cuello A.C., Lleó A., Fortea J.. Basal forebrain atrophy along the Alzheimer's disease continuum in adults with Down syndrome. ALZHEIMERS & DEMENTIA. 2023; 19(11)DOI:10.1002/alz.12999. PMID:37021589. IF:13.100(Q1/1D).

Barroeta, I, Videla, L, Carmona-Iragui, M, Fortea, J, Rafii, MS. Current advances and unmet needs in Alzheimer's disease trials for individuals with Down syndrome: Navigating new therapeutic frontiers. ALZHEIMERS & DEMENTIA. 2025; 21(6)DOI:10.1002/alz.70258. PMID:40528298. IF:11.100(Q1/1D).

Sauer, M, Gomes, BF, Shahrouki, P, Lantero-Rodriguez, J, Montoliu-Gaya, L, Camporesi, E, Belbin, O, Alcolea, D, Kumar, A, Sharma, M, Singh, S, Brinkmalm, G, Gobom, J, Carmona-Iragui, M, Schöll, M, Janelidze, S, Deep, G, Blennow, K, Zetterberg, H, Brinkmalm, A, Lleó, A, Fortea, J, Hansson, O, Ashton, NJ, Nilsson, J. Development and validation of a novel Simoa assay for NPTX2 in Alzheimer's disease and Down syndrome. ALZHEIMERS & DEMENTIA. 2025; 21(6)DOI:10.1002/alz.70241. PMID:40522075. IF:11.100(Q1/1D).

Valle-Tamayo, N, Aranha, MR, Pérez-González, R, Serrano-Requena, S, Videla, L, Barroeta, I, Benejam, B, Chiva-Blanch, G, Jimenez, A, Busciglio, J, Wisniewski, T, Do Carmo, S, Alvarez-Sánchez, E, Muñoz, L, Bejanin, A, Belbin, O, Alcolea, D, Carmona-Iragui, M, Lleó, A, Cuello, AC, Fortea, J, Dols-Icardo, O, Iulita, MF. Nerve growth factor precursor alterations in neuron-derived extracellular vesicles from individuals with Down syndrome along the Alzheimer's disease continuum. ALZHEIMERS & DEMENTIA. 2025; 21(4)DOI:10.1002/alz.70137. PMID:40257051. IF:11.100(Q1/1D).

Ivain, P, Baksh, A, Saini, F, Idris, M, Tamayo-Elizalde, M, Wells, J, Benejam, B, Loosli, SV, Sandkühle, K, Wlasich, E, Wagemann, O, Levin, J, Martet, D, Sacco, S, Falquero, S, Clert, M, Rebillat, AS, Khoo, WM, Smith, MA, Beresford-Webb, J, Zaman, S, Carmona-Iragui, M, Videla, L, Fortea, J, Langballe, EM, Medboen, IT, Larsen, FK, Baldimtsi, E, Paradisi, R, Ntailakis, P, Tsolaki, M, Papantoniou, G, Mcglinchey, E, Mccarron, M, Kennelly, S, Strydom, A. Validation of the CAMCOG-DS-II, a neuropsychological test battery for Alzheimer's disease in people with Down syndrome: A Horizon 21 European Down syndrome Consortium study. ALZHEIMERS & DEMENTIA. 2025; 21(3)DOI:10.1002/alz.70071. PMID:40145416. IF:11.100(Q1/1D).

Koetsier, J, Cavill, R, Reijnders, R, Harvey, J, Homann, J, Kouhsar, M, Deckers, K, Kohler, S, Eijssen, LMT, van den Hove, DLA, Demuth, I, Düzel, S, Smith, RG, Smith, AR, Burrage, J, Walker, EM, Shireby, G, Hannon, E, Dempster, E, Frayling, T, Mill, J, Dobricic, V, Johannsen, P, Wittig, M, Franke, A, Vandenberghe, R, Schaeverbeke, J, Freund-Levi, Y, Frölich, L, Scheltens, P, Teunissen, CE, Frisoni, G, Blin, O, Richardson, JC, Bordet, R, Engelborghs, S, de Roeck, E, Martinez-Lage, P, Tainta, M, Lleó, A, Sala, I, Popp, J, Peyratout, G, Verhey, F, Tsolaki, M, Andreasson, U, Blennow, K, Zetterberg, H, Streffer, J, Vos, SJB, Lovestone, S, Visser, PJ, Lill, CM, Bertram, L, Lunnon, K, Pishva, E. Blood-based multivariate methylation risk score for cognitive impairment and dementia. ALZHEIMERS & DEMENTIA. 2024; 20(10)DOI:10.1002/alz.14061. PMID:39193899. IF:11.100(Q1/1D).

Huber, H, Montoliu-Gaya, L, Brum, WS, Vávra, J, Yakoub, Y, Weninger, H, Braun-Wohlfahrt, LS, Simrén, J, Boada, M, Ruiz, A, Cano, A, Orellana, A, Valero, S, Cañada, L, Tantinya, N, Nogales, AB, Sanz-Cartagena, P, Dittrich, A, Skoog, I, Sander-Long, M, Ballard, C, Richards, M, O'Leary, M, Clemmensen, FK, Wandall, HHD, Altomare, D, Cantoni, V, Stomrud, E, Palmqvist, S, Lleo, A, Alcolea, D, Iragui, MC, Hernandez, AS, Benejam, B, Toro, LV, Singh, A, Denkinger, MN, Simonsen, AH, Kern, S, Corbett, A, Fortea, J, Honigberg, L, Borroni, B, Hansson, O, Morató, X, Blennow, K, Zetterberg, H, Ashton, NJ. A minimally invasive dried blood spot biomarker test for the detection of Alzheimer's disease pathology. NATURE MEDICINE. 2026; 32(2)DOI:10.1038/s41591-025-04080-0. PMID:41491101. IF:50.000(Q1/1D).

Perera-Cruz, O, Solé-Padullés, C, Mulet-Pons, L, Cabello-Toscano, M, Morse, RM, Abellaneda-Pérez, K, Perellón-Alfonso, R, Cattaneo, G, Solana-Sánchez, J, Alviarez-Schulze, V, Bargalló, N, Fortea, J, Tormos, JM, Pascual-Leone, A, Zetterberg, H, Vaqué-Alcázar, L, Bartrés-Faz, D. Cortical mean diffusivity detects early age-related changes and associates with cognition and plasma biomarkers. Brain Communications. 2026; 8(1)DOI:10.1093/braincomms/fcaf511. PMID:41756214. IF:(Q/D).

André, C, Stankeviciute, L, Michaelian, JC, Antonsdottir, IM, Benca, RM, Coulthard, EJ, D'Rozario, AL, Dijk, DJ, Gimenez, S, Gorgoni, M, Leng, Y, Lucey, BP, Pase, MP, Rainey-Smith, SR, Rosenzweig, I, Spira, AP, Winer, JR, Rauchs, G, Naismith, SL. INTERNATIONAL RECOMMENDATIONS FOR SLEEP AND CIRCADIAN RESEARCH IN AGING AND ALZHEIMER'S DISEASE: A DELPHI CONSENSUS STUDY. SLEEP MEDICINE. 2026; 138DOI:. PMID:. IF:3.400(Q2/3D).

Vonk, JMJ, Ferrante, FJ, Morin, BT, Rodriguez, DA, Lin, M, Bogley, R, de Leon, J, Tee, BL, Santos-Santos, MA, Miller, ZA, Mandelli, ML, Gorno-Tempini, ML, García, AM. Automated item-level measures of verbal fluency in semantic and logopenic primary progressive aphasia. ALZHEIMERS & DEMENTIA. 2026; 22(1)DOI:10.1002/alz.71124. PMID:41554669. IF:11.100(Q1/1D).

Suemoto, CK, Paradela, R, Leite, REP, Paes, VR, Pasqualucci, CA, Ferriolli, E, Zatz, M, Santos, GD, de Alexandria, MALS, Pereira, AC, Fortea, J, Naslavsky, M, Grinberg, LT. Apolipoprotein E and Alzheimer's disease pathology in a diverse autopsy study. ALZHEIMERS & DEMENTIA. 2025; 21(11)DOI:10.1002/alz.70927. PMID:41268805. IF:11.100(Q1/1D).

Head, E, Cohen, A, Fortea, J, McGlinchey, E. Novel insights into Alzheimer's disease through the study of individuals with Down syndrome. ALZHEIMERS & DEMENTIA. 2026; 22(1)DOI:10.1002/alz.71074. PMID:41505228. IF:11.100(Q1/1D).

Sánchez-Moreno, B, Zhang, LD, Salaberry, AC, Rozalem-Aranha, M, Moldenhauer, F, Brudfors, M, Ashburner, J, Nachev, P, de Asúa, DR, Strange, BA. Performance of computed tomography and magnetic resonance morphometry in evaluating brain atrophy in Down syndrome. ALZHEIMERS & DEMENTIA. 2025; 21(8)DOI:10.1002/alz.70296. PMID:40762120. IF:11.100(Q1/1D).

Ninou, AH, Caruana, P, Marti, L, Tornero, J, De Llanos, EL, Casas, FC, de la Fuente, N, Aguilar-del Castillo, F, García-Sanchez, C, Cepeda-Franco, C, Padillo-Ruíz, J, Céspedes, MV. CEB-01 membrane loaded with SN-38 for local post-resection control and metastasis reduction in preclinical pancreatic cancer models. Drug Delivery and Translational Research. 2025; DOI:10.1007/s13346-025-02013-5. PMID:41225246. IF:5.500(Q1/1D).

Bebia, V, Díaz-Feijoo, B, Tejerizo, A, Torne, A, Benito, V, Hernández, A, Gorostidi, M, Domingo, S, Bradbury, M, Luna-Guibourg, R, Gil-Moreno, A. Patterns of First Recurrence and Oncological Outcomes in Locally Advanced Cervical Cancer Patients: Does Surgical Staging Play a Role?. Cancers. 2024; 16(7)DOI:10.3390/cancers16071423. PMID:38611101. IF:4.400(Q2/3D).